It seems that the P/LP germline variants of SBDS not only increase the risk of myeloid malignancy, but also may increase the risk of solid tumors like lung cancer; however, the conclusion needs other studies to validate and the underlying mechanisms also need experimental studies to illustrate. The gene discussed is SBDS; the disease is lung carcinoma.